BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26327255)

  • 1. Mammography use and mode of detection among breast cancer patients in Estonia.
    Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
    Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis.
    Onitilo AA; Liang H; Stankowski RV; Engel JM; Broton M; Doi SA; Miskowiak DA
    Rural Remote Health; 2014; 14(3):2738. PubMed ID: 25018129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.
    Baburin A; Aareleid T; Padrik P; Valvere V; Innos K
    Acta Oncol; 2014 Feb; 53(2):226-34. PubMed ID: 23767956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attending breast cancer screening alone does not explain the detection of tumours at an early stage.
    Ouédraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
    Eur J Cancer Prev; 2013 Mar; 22(2):103-11. PubMed ID: 22751208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.
    Silva TB; Mauad EC; Carvalho AL; Jacobs LA; Shulman LN
    Rural Remote Health; 2013; 13(2):2321. PubMed ID: 23597169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
    Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
    Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of mammography and Pap smear in Estonia, a country without organized cancer screening.
    Tekkel M; Veideman T; Baburin A; Rahu M
    Int J Public Health; 2007; 52(2):109-16. PubMed ID: 18704290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportion of women with self-reported opportunistic mammography before organized screening.
    Heikkinen S; Miettinen J; Koskenvuo M; Huovinen R; Pitkäniemi J; Sarkeala T; Malila N
    Acta Oncol; 2016 Jul; 55(7):865-9. PubMed ID: 27144814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Place of residence predicts breast cancer stage at diagnosis in Estonia.
    Innos K; Mägi M; Tekkel M; Aareleid T
    Eur J Public Health; 2011 Jun; 21(3):376-80. PubMed ID: 20237172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis Among DoD Beneficiaries.
    Manjelievskaia J; Brown D; Shao S; Hofmann K; Shriver CD; Zhu K
    Mil Med; 2017 Mar; 182(3):e1782-e1789. PubMed ID: 28290959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
    Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia.
    Innos K; Padrik P; Valvere V; Eelma E; Kütner R; Lehtsaar J; Tekkel M
    BMC Public Health; 2013 Oct; 13():947. PubMed ID: 24107190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
    Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
    Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
    Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
    Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
    Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
    Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes.
    Alenzi EO; Madhavan SS; Tan X
    Breast Cancer Res Treat; 2018 Jan; 167(1):183-193. PubMed ID: 28866828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.